MeiraGTx Holdings (MGTX) Revenue (2019 - 2025)
MeiraGTx Holdings (MGTX) posted Revenue of $75.4 million for Q4 2025, up 18281.46% on a QoQ basis from $410000.0 in Q3 2025, and up 252.33% year-over-year from $21.4 million in Q4 2024.
MeiraGTx Holdings (MGTX) Revenue (2019 - 2025) Analysis & Trends
MeiraGTx Holdings' Revenue history runs 7 years deep, the most recent figure standing at $75.4 million for Q4 2025.
- Quarterly Revenue rose 252.33% year-over-year to $75.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $100.9 million (up 203.06% YoY) and the FY2025 annual result came in at $81.4 million, up 144.57% from the prior year.
- Revenue was $75.4 million for Q4 2025 at MeiraGTx Holdings, up from $410000.0 in the prior quarter.
- Across five years, Revenue topped out at $75.4 million in Q4 2025 and bottomed at -$5.3 million in Q4 2022.
- A 5-year average of $9.5 million and a median of $4.8 million in 2022 frame the typical range for Revenue.
- Annual changes were most pronounced in 2022 — Revenue tumbled 125.13% — and 2025, when it soared 1208.87%.
- MeiraGTx Holdings' Revenue stood at $21.0 million in 2021, then tumbled by 125.13% to -$5.3 million in 2022, then surged by 138.58% to $2.0 million in 2023, then soared by 948.53% to $21.4 million in 2024, then soared by 252.33% to $75.4 million in 2025.
- Business Quant data shows MGTX's Revenue at $75.4 million in Q4 2025, $410000.0 in Q3 2025, and $3.7 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.51 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.99 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 3.61 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.56 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | MeiraGTx Holdings | 973.21 Mn | 907.27 Mn | - | 75.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 75.36 Mn |
| Sep 30, 2025 | 410,000.00 |
| Jun 30, 2025 | 3.69 Mn |
| Dec 31, 2024 | 21.39 Mn |
| Sep 30, 2024 | 10.91 Mn |
| Jun 30, 2024 | 282,000.00 |
| Mar 31, 2024 | 697,000.00 |
| Dec 31, 2023 | 2.04 Mn |
| Sep 30, 2023 | 5.10 Mn |
| Jun 30, 2023 | 3.54 Mn |
| Mar 31, 2023 | 3.33 Mn |
| Dec 31, 2022 | -5.29 Mn |
| Sep 30, 2022 | 4.82 Mn |
| Jun 30, 2022 | 10.76 Mn |
| Mar 31, 2022 | 5.63 Mn |
| Dec 31, 2021 | 21.04 Mn |
| Sep 30, 2021 | 6.95 Mn |
| Jun 30, 2021 | 5.12 Mn |
| Mar 31, 2021 | 4.60 Mn |
| Dec 31, 2020 | 3.79 Mn |